We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHUN icon
12026
Phunware
PHUN
$42.8M
$36K ﹤0.01%
667
-1,680
-72% -$140K
QCLS
12027
Q/C Technologies Inc
QCLS
$21.8M
$36K ﹤0.01%
6
+2
+50% +$18.3K
CMRX
12028
DELISTED
Chimerix, Inc.
CMRX
$36K ﹤0.01%
17,239
-296,789
-95% -$953K
CFIVW
12029
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$36K ﹤0.01%
416,666
BRQS
12030
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$36K ﹤0.01%
+1,800
New +$70.5K
ENTFW
12031
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Warrant
ENTFW
$36K ﹤0.01%
210,015
-389,985
-65% -$101K
MITO
12032
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$36K ﹤0.01%
+141,226
New +$48.6K
CFMS
12033
DELISTED
Conformis, Inc. Common Stock
CFMS
$36K ﹤0.01%
4,097
+2,922
+249% +$33.4K
FVT.WS
12034
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$36K ﹤0.01%
198,875
+58,801
+42% +$22.2K
ENDP
12035
CALL
DELISTED
Endo International plc
ENDP
$36K ﹤0.01%
76,700
-21,000
-21% -$26.7K
XELA
12036
PUT
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$36K ﹤0.01%
80
-70
-47% -$76.1K
CO
12037
CALL
DELISTED
Global Cord Blood Corporation
CO
$36K ﹤0.01%
12,100
-6,600
-35% -$20.5K
CRBP icon
12038
CALL
Corbus Pharmaceuticals
CRBP
$195M
$35K ﹤0.01%
4,630
+543
+13% +$5.25K
DLPN icon
12039
CALL
Dolphin Entertainment
DLPN
$15.6M
$35K ﹤0.01%
5,500
-5,700
-51% -$42.9K
FTEK icon
12040
PUT
Fuel Tech
FTEK
$45.3M
$35K ﹤0.01%
+27,900
New +$36.2K
GDC icon
12041
GD Culture Group
GDC
$7.74M
$35K ﹤0.01%
8
-1
-11% -$5.35K
SJ icon
12042
Scienjoy Holding
SJ
$40.3M
$35K ﹤0.01%
+10,662
New +$33.8K
DCOY
12043
Decoy Therapeutics
DCOY
$2.11M
$35K ﹤0.01%
+5
New +$43.1K
WYY icon
12044
PUT
WidePoint Corp
WYY
$94.5M
$35K ﹤0.01%
14,700
-3,800
-21% -$11.4K
QTTB icon
12045
PUT
Q32 Bio
QTTB
$451M
$35K ﹤0.01%
983
-1,067
-52% -$36.4K
CSCI
12046
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$35K ﹤0.01%
+1,755
New +$43.9K
COOLW
12047
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
$35K ﹤0.01%
705,248
-388,706
-36% -$52.8K
DOMA
12048
DELISTED
Doma Holdings, Inc.
DOMA
$35K ﹤0.01%
1,382
-2,351
-63% -$99.9K
FTVIW
12049
DELISTED
FinTech Acquisition Corp. VI Warrants
FTVIW
$35K ﹤0.01%
246,547
-3,453
-1% -$1.33K
EQOS
12050
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$35K ﹤0.01%
+42,006
New +$56K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.